0 Comment

ASTM F offers multiple aging protocols to determine the effects of time on the sterile integrity and the physical properties of medical packaging. The ASTM F guide provides documentation for developing accelerated aging protocols to promptly determine the effects, if any at all, due to the passage of. Scope of ASTM F • Significance and Use. • Understanding Accelerated Theory & Rationale. • Tolerances and Precision. • Cautions Using Accelerated.

Author: Shakalar Sagal
Country: Finland
Language: English (Spanish)
Genre: Software
Published (Last): 20 March 2012
Pages: 85
PDF File Size: 4.32 Mb
ePub File Size: 5.77 Mb
ISBN: 126-1-13661-565-6
Downloads: 65258
Price: Free* [*Free Regsitration Required]
Uploader: Feramar

Extracted information from ASTM F testing may be used to support expiration date claims for medical device sterile barrier systems.

Historical Version s – view previous versions of standard. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations zstm to use.

Define package material properties, seal strength and integrity tests, sample sizes, and acceptance criteria. Referenced Documents purchase separately The documents listed below are referenced within the subject standard but are not provided as part of the standard.

The resulting creation of an expiration date or shelf life is based on the use of a conservative estimate of the aging factor for example, Q 10 and is tentative until the results of real time aging studies are completed on the sterile barrier system. Define aging test time intervals including time zero. Evaluate the package performance after accelerated aging relative to the initial package requirements.


ASTM F procedure for accelerated aging is comprised of the following: The introduction of new or modified products to the marketplace requires the assurance that they can be stored for an extended period one year, two asrm, etc. Real time studies must be carried out to the claimed shelf life of the product and be performed to their completion.


Work Item s – proposed revisions of this standard. Refer to Practice D for standard conditions that may be used to challenge the sterile barrier system to realistic extremes in temperature and humidity conditions.

Evaluate package, or package performance, or both, after real time aging relative to the initial package requirements. Stability testing shall demonstrate that the sterile barrier system maintains integrity qstm time.

ASTM-F – Accelerated Aging – Medical Package Testing

asgm Accelerated aging studies can provide an alternative means. However, due to market conditions in which products become obsolete in a short time, and the need to get new ff1980 to market in the shortest possible time, real time aging studies do not meet this objective.

Try out our Accelerated Aging Calculator! The sterile barrier system shall maintain sterility to the point of use or until the expiry date. Age samples at TAA. Link to Active This link will always route to the current Active version of the standard.


Determining AAFs are beyond the scope of this guide. Select the Q10 value Define the desired shelf life of the package marketing and product needs, etc. In parallel, age samples at real-life aging conditions TRT. More aggressive AAFs may be used with documented evidence to show a correlation between real time and accelerated aging. F19880 more information visit www.

ASTM-F Standard Guide for Accelerated Aging of Sterile Barrier Systems for Medical Devices The introduction of new or modified products to the marketplace requires the assurance that they can be stored for an extended period one year, two years, etc. To ensure that accelerated aging studies do truly represent real time effects, real time aging studies must be conducted in parallel to accelerated studies. Stability testing using accelerated aging protocols shall be regarded as sufficient evidence for claimed expiry date until data from real time aging studies are available.

The sterile barrier system material and device interaction compatibility that may be required for new product development or the resulting evaluation is not addressed in this guide.